Genetically engineered mouse models of pancreatic cancer.
暂无分享,去创建一个
[1] C. Der,et al. Biological and biochemical properties of human ras H genes mutated at codon 61 , 1986, Cell.
[2] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[3] T. Skaar,et al. MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma1 , 2008, The Journal of Immunology.
[4] S. Dry,et al. PTEN loss accelerates KrasG12D-induced pancreatic cancer development. , 2010, Cancer research.
[5] I. Bross,et al. Environmental factors in cancer of the upper alimentary tract. A swedish study with special reference to plummer‐vinson (Paterson‐Kelly) syndrome , 1957, Cancer.
[6] J B Gibbs,et al. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[7] F. Schabel,et al. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. , 1984, Cancer research.
[8] D. Saur,et al. RCAS-mediated retroviral gene delivery: a versatile tool for the study of gene function in a mouse model of pancreatic cancer. , 2008, Human gene therapy.
[9] Changes in Connexin43 Expression and Localization During Pancreatic Cancer Progression , 2012, The Journal of Membrane Biology.
[10] Drew A. Torigian,et al. CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans , 2011, Science.
[11] P. Spellman,et al. Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.
[12] Fergus J Couch,et al. Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice. , 2011, Gastroenterology.
[13] C. Wright,et al. Ongoing Notch signaling maintains phenotypic fidelity in the adult exocrine pancreas. , 2012, Developmental biology.
[14] T. Wang,et al. Stem cells in gastroenterology and hepatology , 2009, Nature Reviews Gastroenterology &Hepatology.
[15] Thomas G. Caffery,et al. Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer , 2008, Clinical Cancer Research.
[16] D. Tuveson,et al. Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice. , 2011, The Journal of clinical investigation.
[17] Derek S. Chan,et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer , 2012, Gut.
[18] R. Schmid,et al. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. , 2007, Cancer cell.
[19] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[20] A. Capobianco,et al. Notch signalling in solid tumours: a little bit of everything but not all the time , 2011, Nature Reviews Cancer.
[21] H. Friess,et al. From tissue turnover to the cell of origin for pancreatic cancer , 2011, Nature Reviews Gastroenterology &Hepatology.
[22] A. Ashworth,et al. LKB1 Haploinsufficiency Cooperates With Kras to Promote Pancreatic Cancer Through Suppression of p21-Dependent Growth Arrest , 2010, Gastroenterology.
[23] D. Melton,et al. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. , 2002, Development.
[24] T. Mattfeldt,et al. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. , 2001, Genes & development.
[25] J. L. Goodman,et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia , 2008, Proceedings of the National Academy of Sciences.
[26] P. Mazur,et al. Early requirement of Rac1 in a mouse model of pancreatic cancer. , 2011, Gastroenterology.
[27] R. DePinho,et al. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. , 2005, Cancer cell.
[28] H. Tian,et al. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis , 2009, Proceedings of the National Academy of Sciences.
[29] C. Galbán,et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. , 2012, The Journal of clinical investigation.
[30] H. Moses,et al. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. , 2006, Genes & development.
[31] D. Goeddel,et al. Comparative biochemical properties of normal and activated human ras p21 protein , 1984, Nature.
[32] M. Sander,et al. Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas , 2011, Development.
[33] M. Mullendore,et al. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer , 2008, Molecular Cancer Therapeutics.
[34] Frank Buchholz,et al. Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice , 2009, Disease Models & Mechanisms.
[35] Gerald C. Chu,et al. Pancreatic Lkb1 Deletion Leads to Acinar Polarity Defects and Cystic Neoplasms , 2008, Molecular and Cellular Biology.
[36] M. Hebrok,et al. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. , 2010, The Journal of clinical investigation.
[37] N. Jhala,et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. , 2012, Cancer cell.
[38] B. Bao,et al. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. , 2011, Cancer letters.
[39] C. Wright,et al. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors , 2002, Nature Genetics.
[40] Gregory Y. Lauwers,et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.
[41] D. Longnecker. Lesions induced in rodent pancreas by azaserine and other pancreatic carcinogens. , 1984, Environmental health perspectives.
[42] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[43] T. Jacks,et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.
[44] L. Chin,et al. Non-germline genetically engineered mouse models for translational cancer research , 2010, Nature Reviews Cancer.
[45] D. Saur,et al. A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors , 2008, Proceedings of the National Academy of Sciences.
[46] Ralph Weissleder,et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[47] A. Rust,et al. Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma , 2012, Proceedings of the National Academy of Sciences.
[48] D. Tuveson,et al. Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma , 2012, The Journal of experimental medicine.
[49] G. Elder,et al. Animal transgenesis: an overview , 2010, Brain Structure and Function.
[50] M. Barbacid,et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.
[51] Dissecting the Cellular Origins of Pancreatic Cancer , 2006, Cell cycle.
[52] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[53] H. Ku. Minireview: pancreatic progenitor cells--recent studies. , 2008, Endocrinology.
[54] J. Cameron,et al. Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray , 2003, Modern Pathology.
[55] Gerald C. Chu,et al. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. , 2009, Cancer cell.
[56] Carlos Cuevas,et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.
[57] D. Tuveson,et al. K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses. , 2008, Methods in enzymology.
[58] C. Der,et al. Inhibition of Ras for cancer treatment: the search continues. , 2011, Future medicinal chemistry.
[59] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[60] M. Korc,et al. Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions. , 2011, Gastroenterology.
[61] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[62] M. Korc,et al. The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia , 2007, Proceedings of the National Academy of Sciences.
[63] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[64] D. Tuveson,et al. nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. , 2012, Cancer discovery.
[65] M. Barbacid,et al. What we have learned about pancreatic cancer from mouse models. , 2012, Gastroenterology.
[66] J. Deng,et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine , 2011, Nature Genetics.
[67] D. Tuveson,et al. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.
[68] J. Feramisco,et al. The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity , 1984, Nature.
[69] Paul Timpson,et al. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer , 2010, Proceedings of the National Academy of Sciences.
[70] M. Hollingsworth,et al. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer , 2009, Oncogene.
[71] R. Hruban,et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. , 2003, Cancer cell.
[72] D. Bar-Sagi,et al. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. , 2012, Cancer cell.
[73] Gerald C. Chu,et al. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. , 2009, Genes & development.
[74] F. C. Pan,et al. Pancreas organogenesis: From bud to plexus to gland , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.
[75] David J. Anderson,et al. Notch signalling controls pancreatic cell differentiation , 1999, Nature.
[76] Jason R. Gunn,et al. Acute Pancreatitis Accelerates Initiation and Progression to Pancreatic Cancer in Mice Expressing Oncogenic Kras in the Nestin Cell Lineage , 2011, PloS one.
[77] T. Schoeb,et al. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. , 2007, Cancer research.
[78] R. Hruban,et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. , 2007, Cancer cell.
[79] Gerald C. Chu,et al. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. , 2011, Cancer discovery.
[80] T. Ludwig,et al. BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity , 2011, Science.
[81] Todd E. Scheetz,et al. Somatic Mutagenesis with a Sleeping Beauty Transposon System Leads to Solid Tumor Formation in Zebrafish , 2011, PloS one.
[82] Ashok R Venkitaraman,et al. Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer. , 2010, Cancer cell.
[83] J. Norman,et al. Mutant p53 Drives Invasion by Promoting Integrin Recycling , 2009, Cell.
[84] G. Kristiansen,et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma , 2012, Nature.
[85] Gerald C. Chu,et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. , 2006, Genes & development.
[86] Mallika Singh,et al. Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models , 2010, Nature Biotechnology.
[87] L. C. Murtaugh,et al. Pancreatic stem cells , 2008 .
[88] Malte Buchholz,et al. Stromal biology and therapy in pancreatic cancer , 2010, Gut.
[89] R. Rad,et al. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma , 2010, Proceedings of the National Academy of Sciences.
[90] D. Tuveson,et al. Suppression of BRAF(V599E) in human melanoma abrogates transformation. , 2003, Cancer research.
[91] Brian Bierie,et al. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. , 2011, The Journal of clinical investigation.
[92] J. Kench,et al. Stabilization of beta-catenin induces pancreas tumor formation. , 2008, Gastroenterology.
[93] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[94] A. Maitra,et al. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.